
Maria Marvich
Examiner (ID: 9363)
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633, 1634, 1631, 1636 |
| Total Applications | 1459 |
| Issued Applications | 618 |
| Pending Applications | 253 |
| Abandoned Applications | 627 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5042464
[patent_doc_number] => 20070094746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Hybrid caulimovirus promoters and constructs thereof'
[patent_app_type] => utility
[patent_app_number] => 11/544544
[patent_app_country] => US
[patent_app_date] => 2006-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 23307
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20070094746.pdf
[firstpage_image] =>[orig_patent_app_number] => 11544544
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/544544 | Hybrid caulimovirus promoters and constructs thereof | Oct 5, 2006 | Abandoned |
Array
(
[id] => 4898867
[patent_doc_number] => 20080118481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-22
[patent_title] => 'Mononuclear phagocytes in therapeutic drug delivery'
[patent_app_type] => utility
[patent_app_number] => 11/543760
[patent_app_country] => US
[patent_app_date] => 2006-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10268
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20080118481.pdf
[firstpage_image] =>[orig_patent_app_number] => 11543760
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/543760 | Mononuclear phagocytes in therapeutic drug delivery | Oct 3, 2006 | Abandoned |
Array
(
[id] => 12490734
[patent_doc_number] => 09994858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Constructs for gene expression analysis
[patent_app_type] => utility
[patent_app_number] => 11/542982
[patent_app_country] => US
[patent_app_date] => 2006-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 42
[patent_no_of_words] => 29130
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11542982
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/542982 | Constructs for gene expression analysis | Oct 3, 2006 | Issued |
Array
(
[id] => 5206841
[patent_doc_number] => 20070028323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Artificial bidirectional promoter for activation of gene expression'
[patent_app_type] => utility
[patent_app_number] => 11/542590
[patent_app_country] => US
[patent_app_date] => 2006-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6291
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20070028323.pdf
[firstpage_image] =>[orig_patent_app_number] => 11542590
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/542590 | Artificial bidirectional promoter for activation of gene expression | Oct 2, 2006 | Issued |
Array
(
[id] => 5243999
[patent_doc_number] => 20070022494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Cotton plants having vegetative and reproductive tolerance to glyphosate'
[patent_app_type] => utility
[patent_app_number] => 11/526441
[patent_app_country] => US
[patent_app_date] => 2006-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 23302
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20070022494.pdf
[firstpage_image] =>[orig_patent_app_number] => 11526441
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/526441 | Cotton plants having vegetative and reproductive tolerance to glyphosate | Sep 24, 2006 | Abandoned |
Array
(
[id] => 5193499
[patent_doc_number] => 20070081983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Isolation of smooth muscle cells and tissue-engineered vasculature containing the isolated cells'
[patent_app_type] => utility
[patent_app_number] => 11/523474
[patent_app_country] => US
[patent_app_date] => 2006-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 11588
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20070081983.pdf
[firstpage_image] =>[orig_patent_app_number] => 11523474
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/523474 | Isolation of smooth muscle cells and tissue-engineered vasculature containing the isolated cells | Sep 18, 2006 | Abandoned |
Array
(
[id] => 5034729
[patent_doc_number] => 20070099268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Chimeric HCN channels'
[patent_app_type] => utility
[patent_app_number] => 11/519399
[patent_app_country] => US
[patent_app_date] => 2006-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 72
[patent_figures_cnt] => 72
[patent_no_of_words] => 42383
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20070099268.pdf
[firstpage_image] =>[orig_patent_app_number] => 11519399
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/519399 | Chimeric HCN channels | Sep 10, 2006 | Abandoned |
Array
(
[id] => 4971281
[patent_doc_number] => 20070111283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Vector system for selection of genes encoding secreted proteins and membrane-bound proteins'
[patent_app_type] => utility
[patent_app_number] => 11/514476
[patent_app_country] => US
[patent_app_date] => 2006-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10620
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20070111283.pdf
[firstpage_image] =>[orig_patent_app_number] => 11514476
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/514476 | Vector system for selection of genes encoding secreted proteins and membrane-bound proteins | Aug 30, 2006 | Abandoned |
Array
(
[id] => 5688922
[patent_doc_number] => 20060287237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'RhoB as a suppressor of cancer cell growth, cell transformation, and metastasis'
[patent_app_type] => utility
[patent_app_number] => 11/512563
[patent_app_country] => US
[patent_app_date] => 2006-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 13851
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287237.pdf
[firstpage_image] =>[orig_patent_app_number] => 11512563
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/512563 | RhoB as a suppressor of cancer cell growth, cell transformation, and metastasis | Aug 29, 2006 | Issued |
Array
(
[id] => 5601778
[patent_doc_number] => 20060292123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Adeno-associated virus-mediated delivery of GDNF to skeletal muscles'
[patent_app_type] => utility
[patent_app_number] => 11/511102
[patent_app_country] => US
[patent_app_date] => 2006-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19729
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292123.pdf
[firstpage_image] =>[orig_patent_app_number] => 11511102
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/511102 | Adeno-associated virus-mediated delivery of GDNF to skeletal muscles | Aug 27, 2006 | Abandoned |
Array
(
[id] => 6492515
[patent_doc_number] => 20100093617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'Use'
[patent_app_type] => utility
[patent_app_number] => 11/990885
[patent_app_country] => US
[patent_app_date] => 2006-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 41566
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 45
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093617.pdf
[firstpage_image] =>[orig_patent_app_number] => 11990885
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/990885 | Method of modulating cell resistance | Aug 24, 2006 | Issued |
Array
(
[id] => 5106535
[patent_doc_number] => 20070065412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Production of recombinant AAV using adenovirus comprising AAV rep/cap genes'
[patent_app_type] => utility
[patent_app_number] => 11/509855
[patent_app_country] => US
[patent_app_date] => 2006-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17281
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065412.pdf
[firstpage_image] =>[orig_patent_app_number] => 11509855
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/509855 | Production of recombinant AAV using adenovirus comprising AAV rep/cap genes | Aug 24, 2006 | Abandoned |
Array
(
[id] => 5005017
[patent_doc_number] => 20070202587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Recombinant AAV production in mammalian cells'
[patent_app_type] => utility
[patent_app_number] => 11/503775
[patent_app_country] => US
[patent_app_date] => 2006-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15033
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20070202587.pdf
[firstpage_image] =>[orig_patent_app_number] => 11503775
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/503775 | Recombinant AAV production in mammalian cells | Aug 13, 2006 | Abandoned |
Array
(
[id] => 5258700
[patent_doc_number] => 20070212332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Methods for accelerating bone repair'
[patent_app_type] => utility
[patent_app_number] => 11/503365
[patent_app_country] => US
[patent_app_date] => 2006-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 33179
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20070212332.pdf
[firstpage_image] =>[orig_patent_app_number] => 11503365
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/503365 | Methods for accelerating bone repair | Aug 9, 2006 | Abandoned |
Array
(
[id] => 14172101
[patent_doc_number] => 10260049
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-16
[patent_title] => Attenuated reovirus
[patent_app_type] => utility
[patent_app_number] => 11/997537
[patent_app_country] => US
[patent_app_date] => 2006-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 27
[patent_no_of_words] => 17002
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11997537
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997537 | Attenuated reovirus | Jul 30, 2006 | Issued |
Array
(
[id] => 5107034
[patent_doc_number] => 20070065912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Multiple Gene Expression including sORF Constructs and Methods with Polyproteins, Pro-Proteins, and Proteolysis'
[patent_app_type] => utility
[patent_app_number] => 11/459098
[patent_app_country] => US
[patent_app_date] => 2006-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 53791
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065912.pdf
[firstpage_image] =>[orig_patent_app_number] => 11459098
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/459098 | Multiple Gene Expression including sORF Constructs and Methods with Polyproteins, Pro-Proteins, and Proteolysis | Jul 20, 2006 | Abandoned |
Array
(
[id] => 5661530
[patent_doc_number] => 20060252126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Polypeptides having phospholipase B activity and nucleic acids encoding same'
[patent_app_type] => utility
[patent_app_number] => 11/489301
[patent_app_country] => US
[patent_app_date] => 2006-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19526
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252126.pdf
[firstpage_image] =>[orig_patent_app_number] => 11489301
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/489301 | Polypeptides having phospholipase B activity and nucleic acids encoding same | Jul 17, 2006 | Abandoned |
Array
(
[id] => 5236021
[patent_doc_number] => 20070128177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders'
[patent_app_type] => utility
[patent_app_number] => 11/488520
[patent_app_country] => US
[patent_app_date] => 2006-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 21532
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20070128177.pdf
[firstpage_image] =>[orig_patent_app_number] => 11488520
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/488520 | Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders | Jul 16, 2006 | Abandoned |
Array
(
[id] => 5662128
[patent_doc_number] => 20060252724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Method and composition for modulating bone growth'
[patent_app_type] => utility
[patent_app_number] => 11/486532
[patent_app_country] => US
[patent_app_date] => 2006-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15602
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252724.pdf
[firstpage_image] =>[orig_patent_app_number] => 11486532
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/486532 | Method and composition for modulating bone growth | Jul 13, 2006 | Abandoned |
Array
(
[id] => 6466833
[patent_doc_number] => 20100040578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'Malignant Tumor Cell Suppressor Protein, Malignant Tumor Cell Suppressor Gene, Maligant Tumor Cell Suppressive Viral Vector, and Kit Using the Same'
[patent_app_type] => utility
[patent_app_number] => 11/922933
[patent_app_country] => US
[patent_app_date] => 2006-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6205
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20100040578.pdf
[firstpage_image] =>[orig_patent_app_number] => 11922933
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/922933 | Malignant tumor cell suppressor protein, malignant tumor cell suppressor gene, maligant tumor cell suppressive viral vector, and kit using the same | Jun 29, 2006 | Issued |